ES505544A0 - Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina - Google Patents

Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina

Info

Publication number: ES505544A0
Authority: ES; Spain
Prior art keywords: piridi; procedure; preparation; pirimidine derivatives; pirimidine
Prior art date: 1979-10-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES505544A

Other languages

English (en)

Other versions

ES8206478A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-10-15

Filing date

1981-09-16

Publication date

1982-08-16

1981-09-16 Application filed by Pfizer Inc filed Critical Pfizer Inc

1982-08-16 Publication of ES505544A0 publication Critical patent/ES505544A0/es

1982-08-16 Publication of ES8206478A1 publication Critical patent/ES8206478A1/es

Status Expired legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01D—HARVESTING; MOWING
- A01D34/00—Mowers; Mowing apparatus of harvesters
- A01D34/001—Accessories not otherwise provided for
- A01D34/003—Means for cleaning the machine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C33/00—Moulds or cores; Details thereof or accessories therefor
- B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
- B29C33/60—Releasing, lubricating or separating agents
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
- B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
- B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
- F16C11/00—Pivots; Pivotal connections
- F16C11/04—Pivotal connections
- F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
- F16C11/0604—Construction of the male part
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
- F16C11/00—Pivots; Pivotal connections
- F16C11/04—Pivotal connections
- F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
- F16C11/068—Special features relating to lubrication

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Mechanical Engineering (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Composite Materials (AREA)
Environmental Sciences (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

ES505544A 1979-10-15 1981-09-16 Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina Expired ES8206478A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/085,011 US4246263A (en)	1979-10-15	1979-10-15	Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
ES505544A0 true ES505544A0 (es)	1982-08-16
ES8206478A1 ES8206478A1 (es)	1982-08-16

Family

ID=22188737

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES495932A Granted ES495932A0 (es)	1979-10-15	1980-10-14	Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES505544A Expired ES8206478A1 (es)	1979-10-15	1981-09-16	Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
ES495932A Granted ES495932A0 (es)	1979-10-15	1980-10-14	Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.

Country Status (39)

Country	Link
US (1)	US4246263A (es)
JP (1)	JPS5663962A (es)
KR (2)	KR840001614B1 (es)
AR (3)	AR226864A1 (es)
AT (2)	AT377513B (es)
AU (1)	AU517763B2 (es)
BE (1)	BE885709A (es)
CA (1)	CA1156231A (es)
CH (1)	CH646425A5 (es)
CS (2)	CS226020B2 (es)
DD (2)	DD154816B3 (es)
DE (1)	DE3038593A1 (es)
DK (1)	DK152427C (es)
EG (1)	EG14676A (es)
ES (2)	ES495932A0 (es)
FI (1)	FI75560C (es)
FR (1)	FR2467199A1 (es)
GB (2)	GB2092133B (es)
GR (1)	GR70311B (es)
HK (2)	HK1185A (es)
HU (2)	HU191824B (es)
IE (1)	IE50665B1 (es)
IL (1)	IL61261A (es)
IN (2)	IN154554B (es)
IT (1)	IT1195269B (es)
KE (2)	KE3461A (es)
LU (1)	LU82844A1 (es)
MY (2)	MY8500323A (es)
NL (1)	NL8005652A (es)
NO (1)	NO156566C (es)
NZ (1)	NZ195246A (es)
PH (1)	PH18277A (es)
PL (2)	PL125402B1 (es)
PT (1)	PT71917B (es)
SE (1)	SE437023B (es)
SG (2)	SG56384G (es)
SU (2)	SU1083907A3 (es)
YU (2)	YU41740B (es)
ZA (1)	ZA806306B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4371696A (en) *	1980-07-14	1983-02-01	Pfizer Inc.	Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) *	1984-03-07	1984-04-11	Sandoz Ltd	Organic compounds
JPH01502980A (ja) *	1986-06-17	1989-10-12	レイチ，スティーブン　デー	ガンマインターフェロンと抗炎症剤または抗発熱剤との組合せ並びに疾患処置方法
WO2003024955A2 (en) *	2001-09-18	2003-03-27	Sunesis Pharmaceuticals, Inc.	Small molecule inhibitors of caspases
EP1896401B1 (en) *	2005-02-25	2013-04-10	Temple University - Of The Commonwealth System of Higher Education	Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
JP5287033B2 (ja) *	2007-08-23	2013-09-11	住友化学株式会社	含フッ素有機硫黄化合物およびその有害節足動物防除剤
CN108530606B (zh) *	2018-04-19	2020-11-20	山东师范大学	一种pH敏感性医用聚氨酯脲材料及其制备方法
US11981625B2 (en)	2018-10-08	2024-05-14	Ecolab Usa Inc.	Sulfide-based compounds and uses thereof
CN110483740B (zh) *	2019-08-12	2021-08-27	山东师范大学	一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3409626A (en) *	1963-09-17	1968-11-05	Neisler Lab Inc	Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) *	1967-07-26	1975-01-15	Merck & Co Inc	Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) *	1967-12-20	1971-01-26	Merck & Co Inc	Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) *	1968-08-05	1972-01-18	Hooker Chemical Corp	Novel mercaptophenol derivatives
US3591584A (en)	1968-08-27	1971-07-06	Pfizer	Benzothiazine dioxides
US3818009A (en) *	1969-12-29	1974-06-18	Lilly Co Eli	Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en)	1970-10-15	1972-07-11	Pfizer	Oxobenzofuran carboxamides
US3707475A (en)	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
JPS52125170A (en) *	1976-04-12	1977-10-20	Yoshitomi Pharmaceut Ind Ltd	Pyridine derivatives

1979
- 1979-10-15 US US06/085,011 patent/US4246263A/en not_active Expired - Lifetime
1980
- 1980-08-16 IN IN597/DEL/80A patent/IN154554B/en unknown
- 1980-09-24 DK DK403080A patent/DK152427C/da not_active IP Right Cessation
- 1980-10-09 AR AR282823A patent/AR226864A1/es active
- 1980-10-10 CA CA000362238A patent/CA1156231A/en not_active Expired
- 1980-10-11 GR GR63147A patent/GR70311B/el unknown
- 1980-10-13 GB GB8137997A patent/GB2092133B/en not_active Expired
- 1980-10-13 GB GB8032971A patent/GB2061928B/en not_active Expired
- 1980-10-13 AT AT0508980A patent/AT377513B/de not_active IP Right Cessation
- 1980-10-13 NZ NZ195246A patent/NZ195246A/en unknown
- 1980-10-13 IL IL61261A patent/IL61261A/xx unknown
- 1980-10-13 YU YU2626/80A patent/YU41740B/xx unknown
- 1980-10-13 DE DE19803038593 patent/DE3038593A1/de active Granted
- 1980-10-13 LU LU82844A patent/LU82844A1/fr unknown
- 1980-10-14 EG EG80638A patent/EG14676A/xx active
- 1980-10-14 JP JP14357280A patent/JPS5663962A/ja active Granted
- 1980-10-14 ZA ZA00806306A patent/ZA806306B/xx unknown
- 1980-10-14 FR FR8021931A patent/FR2467199A1/fr active Granted
- 1980-10-14 IE IE2125/80A patent/IE50665B1/en unknown
- 1980-10-14 NL NL8005652A patent/NL8005652A/nl not_active Application Discontinuation
- 1980-10-14 SU SU802993951A patent/SU1083907A3/ru active
- 1980-10-14 SE SE8007193A patent/SE437023B/sv not_active IP Right Cessation
- 1980-10-14 FI FI803239A patent/FI75560C/fi not_active IP Right Cessation
- 1980-10-14 DD DD80224544A patent/DD154816B3/de not_active IP Right Cessation
- 1980-10-14 HU HU83101A patent/HU191824B/hu not_active IP Right Cessation
- 1980-10-14 PH PH24725A patent/PH18277A/en unknown
- 1980-10-14 AU AU63240/80A patent/AU517763B2/en not_active Ceased
- 1980-10-14 NO NO803073A patent/NO156566C/no unknown
- 1980-10-14 BE BE0/202467A patent/BE885709A/fr not_active IP Right Cessation
- 1980-10-14 PT PT71917A patent/PT71917B/pt unknown
- 1980-10-14 IT IT25324/80A patent/IT1195269B/it active
- 1980-10-14 ES ES495932A patent/ES495932A0/es active Granted
- 1980-10-14 HU HU802494A patent/HU183233B/hu not_active IP Right Cessation
- 1980-10-15 CS CS806985A patent/CS226020B2/cs unknown
- 1980-10-15 PL PL1980231782A patent/PL125402B1/pl unknown
- 1980-10-15 CH CH771980A patent/CH646425A5/fr not_active IP Right Cessation
- 1980-10-15 KR KR1019800003966A patent/KR840001614B1/ko active
- 1980-10-15 PL PL1980227307A patent/PL125314B1/pl unknown
1981
- 1981-09-08 CS CS816610A patent/CS226034B2/cs unknown
- 1981-09-16 ES ES505544A patent/ES8206478A1/es not_active Expired
- 1981-11-04 SU SU813349450A patent/SU1144617A3/ru active
1982
- 1982-01-18 DD DD82236826A patent/DD202543A5/de not_active IP Right Cessation
- 1982-02-18 AR AR288464A patent/AR227576A1/es active
- 1982-02-18 AR AR288463A patent/AR227089A1/es active
- 1982-12-01 YU YU2668/82A patent/YU42059B/xx unknown
1983
- 1983-07-22 AT AT0268783A patent/AT379801B/de not_active IP Right Cessation
1984
- 1984-06-05 IN IN464/DEL/84A patent/IN163553B/en unknown
- 1984-08-13 SG SG563/84A patent/SG56384G/en unknown
- 1984-08-22 KR KR1019840005076A patent/KR840001615B1/ko not_active IP Right Cessation
- 1984-09-24 KE KE3461A patent/KE3461A/xx unknown
- 1984-09-25 SG SG691/84A patent/SG69184G/en unknown
- 1984-10-05 KE KE3466A patent/KE3466A/xx unknown
1985
- 1985-01-03 HK HK11/85A patent/HK1185A/xx unknown
- 1985-12-30 MY MY323/85A patent/MY8500323A/xx unknown
- 1985-12-30 MY MY325/85A patent/MY8500325A/xx unknown
1987
- 1987-09-17 HK HK668/87A patent/HK66887A/xx unknown

Also Published As

Publication number	Publication date
KR840001615B1 (ko)	1984-10-11
YU266882A (en)	1983-09-30
NO803073L (no)	1981-04-21
PL231782A1 (es)	1982-03-01
KE3466A (en)	1984-11-09
GB2092133A (en)	1982-08-11
GR70311B (es)	1982-09-08
PL125314B1 (en)	1983-04-30
SG56384G (en)	1985-03-08
DE3038593A1 (de)	1981-04-23
ATA268783A (de)	1985-07-15
YU262680A (en)	1983-09-30
FI75560B (fi)	1988-03-31
ES8201972A1 (es)	1982-01-16
IT1195269B (it)	1988-10-12
AR227089A1 (es)	1982-09-15
IL61261A0 (en)	1980-12-31
SE437023B (sv)	1985-02-04
FI75560C (fi)	1988-07-11
CH646425A5 (fr)	1984-11-30
SU1083907A3 (ru)	1984-03-30
AT379801B (de)	1986-03-10
KE3461A (en)	1984-10-12
PH18277A (en)	1985-05-17
HU183233B (en)	1984-04-28
JPS6129342B2 (es)	1986-07-05
FR2467199B1 (es)	1984-12-28
MY8500323A (en)	1985-12-31
GB2061928B (en)	1983-06-02
YU42059B (en)	1988-04-30
PT71917A (en)	1980-12-01
NZ195246A (en)	1983-07-15
SU1144617A3 (ru)	1985-03-07
AT377513B (de)	1985-03-25
FR2467199A1 (fr)	1981-04-17
DD154816A5 (de)	1982-04-21
DD202543A5 (de)	1983-09-21
EG14676A (en)	1985-03-31
NO156566B (no)	1987-07-06
IL61261A (en)	1984-08-31
AU6324080A (en)	1981-04-30
HU191824B (en)	1987-04-28
CS226020B2 (en)	1984-03-19
KR830004263A (ko)	1983-07-09
IN163553B (es)	1988-10-08
GB2061928A (en)	1981-05-20
KR840001614B1 (ko)	1984-10-11
AU517763B2 (en)	1981-08-27
FI803239L (fi)	1981-04-16
US4246263A (en)	1981-01-20
YU41740B (en)	1987-12-31
IE802125L (en)	1981-04-15
PL227307A1 (es)	1981-11-13
CA1156231A (en)	1983-11-01
ZA806306B (en)	1981-10-28
DK152427B (da)	1988-02-29
DK403080A (da)	1981-04-16
DD154816B3 (de)	1987-05-13
DK152427C (da)	1988-07-25
AR227576A1 (es)	1982-11-15
SG69184G (en)	1985-03-15
IE50665B1 (en)	1986-06-11
GB2092133B (en)	1983-03-16
ATA508980A (de)	1984-08-15
SE8007193L (sv)	1981-04-16
ES495932A0 (es)	1982-01-16
DE3038593C2 (es)	1988-11-10
CS226034B2 (en)	1984-03-19
JPS5663962A (en)	1981-05-30
PT71917B (en)	1983-01-10
LU82844A1 (fr)	1981-06-04
HK66887A (en)	1987-09-25
BE885709A (fr)	1981-04-14
MY8500325A (en)	1985-12-31
PL125402B1 (en)	1983-05-31
NL8005652A (nl)	1981-04-21
AR226864A1 (es)	1982-08-31
IN154554B (es)	1984-11-10
NO156566C (no)	1987-10-14
ES8206478A1 (es)	1982-08-16
HK1185A (en)	1985-01-11
IT8025324A0 (it)	1980-10-14

Legal Events

Date	Code	Title	Description
1997-04-01	FD1A	Patent lapsed	Effective date: 19970303

Publication	Publication Date	Title
ES505548A0 (es)	1982-06-01	Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano
AR222204A1 (es)	1981-04-30	Un procedimiento para la preparacion de derivados de i-bencilimidazol
ES497640A0 (es)	1981-11-16	Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES489752A0 (es)	1981-02-16	Un procedimiento para la preparacion de un derivado de imi- dazolidindiona
ES501805A0 (es)	1982-05-16	Un procedimiento para la preparacion de derivados de la eta-nolamina
ES496798A0 (es)	1981-11-16	Un procedimiento para la preparacion de un derivado de aze- tidina
ES495892A0 (es)	1981-12-01	Un procedimiento para la preparacion de metacroleina
ES493579A0 (es)	1981-06-16	Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES490510A0 (es)	1981-04-16	Un procedimiento para la preparacion de derivados de penici-lina
ES489470A0 (es)	1981-04-16	Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES491370A0 (es)	1981-05-16	Un procedimiento para la preparacion de piridizinobenzodiazepinas
ES496487A0 (es)	1981-10-01	Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles
ES505555A0 (es)	1982-06-01	Un procedimiento para la preparacion de derivados de imida- zol
ES505544A0 (es)	1982-08-16	Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina
ES495865A0 (es)	1981-12-01	Un procedimiento para la preparacion de derivados de quina- zolina
ES491992A0 (es)	1981-06-01	Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano
ES490667A0 (es)	1981-05-16	Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico
ES490289A0 (es)	1981-10-16	Un procedimiento para la preparacion de derivados de xantina
ES490022A0 (es)	1981-04-16	Un procedimiento para la preparacion de imidazobenzodiacepi-nas
ES500381A0 (es)	1982-12-01	Un procedimiento para la preparacion de derivados de pirro- lidina
ES488231A0 (es)	1980-12-16	Un procedimiento para la preparacion de derivados de penici-lina o de cefalosporina
AR222208A1 (es)	1981-04-30	Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina
ES491662A0 (es)	1981-06-01	Un procedimiento para la preparacion de un pirazol cuaterna-rio
ES489227A0 (es)	1981-02-16	Un procedimiento para la preparacion de un derivado de pira-zol
ES492539A0 (es)	1981-06-01	Un procedimiento para la preparacion de pirencepina